article Open AccessTop 1% cited
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
New England Journal of Medicine · 2005 · Vol. 352(15) · pp. 1539–1549
John G.F. Cleland✉(King's College Hospital)Jean‐Claude Daubert(Hôpital Pontchaillou)Erland Erdmann(University of Cologne)Nick Freemantle(The Edgbaston Hospital)Daniel Gras(Nouvelles Cliniques Nantaises)Lukas Kappenberger(University Hospital of Lausanne)Luigi Tavazzi(Istituti di Ricovero e Cura a Carattere Scientifico)
Abstract
In patients with heart failure and cardiac dyssynchrony, cardiac resynchronization improves symptoms and the quality of life and reduces complications and the risk of death. These benefits are in addition to those afforded by standard pharmacologic therapy. The implantation of a cardiac-resynchronization device should routinely be considered in such patients.
Cardiac pacing and defibrillation studiesCardiovascular Function and Risk FactorsCardiomyopathy and Myosin StudiesMedicineCardiac resynchronization therapyHeart failureCardiologyInternal medicineHazard ratioEjection fractionVentricular dyssynchronyConfidence intervalClinical endpoint
MeSH terms
AgedCardiac Pacing, ArtificialCombined Modality TherapyFemaleFollow-Up StudiesHeart FailureHospitalizationHumansMaleMiddle AgedMyocardial ContractionPacemaker, ArtificialStroke VolumeSurvival AnalysisVentricular Dysfunction, Left
Citations
6,231
FWCI
263.14
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Circulation · 2013 · 3,289 citations
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
European Heart Journal · 2015 · 3,863 citations
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
European Heart Journal · 2022 · 2,635 citations
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal · 2016 · 11,387 citations
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
European Heart Journal · 2005 · 2,257 citations
Defining Left Bundle Branch Block in the Era of Cardiac Resynchronization Therapy
The American Journal of Cardiology · 2011 · 674 citations
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
European Heart Journal · 2008 · 2,692 citations
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
European Heart Journal · 2012 · 6,892 citations
References
Discrete sequential boundaries for clinical trials
Biometrika · 1983 · 1,735 citations
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
The American Journal of Cardiology · 1988 · 3,772 citations
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
New England Journal of Medicine · 2005 · 6,492 citations
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
The Lancet · 1999 · 4,886 citations
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
New England Journal of Medicine · 1999 · 9,024 citations
Discrete Sequential Boundaries for Clinical Trials
Biometrika · 1983 · 1,675 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
